|Last Price||Today's Change||52-Week Range||Trading Volume|
|67.71||0.00 (0.00%)||45.50 - 70.76||677.1 thousand (Below Avg)|
Market data as of 12:00AM 12/19/14. Quotes are delayed by at least 15 min.
AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199) in Acute Myelogenous Leukemia at the 56th American Society of Hematology Annual Meeting
12/07/2014 8:15 PM ET